Research Discoveries Offer Optimism and Hope for Alzheimer’s Patients
Recently John C. Morris, MD, Director of the Knight Alzheimer Disease Research Center at Washington University in St. Louis and member of the ABF research advisory committee, said there are several reasons to have hope and optimism for the future regarding Alzheimer’s disease. Involved in Alzheimer’s research since 1983, he explained for the first time he believes “there is now a great opportunity to develop effective therapies, including drugs currently under evaluation for treatment.” He said advances also include an important tool for diagnosing the disease.
One of the reasons for optimism was the announcement of the pharmaceutical company Biogen’s controversial new drug, which purportedly is designed to treat Alzheimer’s disease and not just the symptoms. The drug, aducanumab, was approved for patient use on June 7, 2021. However, doctors say it is important to know the FDA’s approval is only for the drug’s ability to reduce the amount of amyloid plaques in the brains of people given the drug. They state it is still unknown whether the removal of the plaque offers benefits to the patients. To be eligible to receive the drug, patients need to have a firm diagnosis of Alzheimer’s disease.
In the year 2020, we also heard the news about a ground-breaking new blood test at the Alzheimer’s Association International Conference 2020. Researchers say the new test identifies the protein ptau-2017, a biomarker for Alzheimer’s, and results have been far more accurate than several other biomarkers currently being tested. This is good news as doctors say earlier testing will lead to earlier interventions. The test received a Breakthrough Device designation by the FDA in October 2021.
Along with assisted living, the new MorningStar of San Jose will offer 34 suites devoted to the compassionate, loving care of those with memory impairment. Our holistic care is individualized for each resident and every aspect of our Reflections Neighborhood is tailored to serve the needs of our most tender residents. Our job is to elevate and celebrate life by trying to connect with and nurture the individual each day, and to ensure they are treated with the utmost respect and dignity they deserve. For more information about trusted memory care at MorningStar, please contact us or visit our website.
At MorningStar of San Jose, our mission statement “to honor, to serve, to invest” sets us apart from other senior living communities. We have built a foundation on honoring God, valuing our seniors and selecting staff with a felt calling to serve. Set in a warm, loving atmosphere with beautiful surroundings and resort-style amenities, we provide residents exceptional assisted living facilities and memory care.
Source: americanbrainfoundation.org/research-in-dementia-2022/